Is Biochemical Follow Up Possible in Peripheral Arterial Disease Treatment: Hypoxia Inducible Factor-1 Alpha?

Cihan Yücel Mete Gürsoy Serkan Ketenciler Aslıhan Tenekeciğil Feryaz Kızıltan Nihan Kayalar

Published in: Vascular specialist international (2021)

The HIF-1α levels were decreased in all patients on postoperative days, T2 and T3, compared with the preoperative values. Our results indicated that HIF-1α may be a surrogate marker after revascularization in patients with PAD. Further studies are needed to analyze the sensitivity, specificity, and cut-off values of HIF-1α in patients with PAD.

Keyphrases

end stage renal disease
patients undergoing
endothelial cells
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
combination therapy
replacement therapy
patient reported